发育期麻醉神经毒性临床前研究与发表标准:SmartTots专家意见
2019年3月,SmartTots召开会议讨论围产期麻醉神经毒性临床前研究的严谨性与报告标准。专家组确认临床前研究的重要性,总结动物模型优缺点并提出报告指南,为设计新实验和跨实验室结果解读提供实用路线图。
要点
- 临床前研究对围产期麻醉神经毒性领域至关重要,应欢迎新机制方法。
- 总结特定模型系统的优缺点有助于设计新实验和跨实验室结果解读。
- 本专家意见提供当前动物模型聚焦综述和报告标准,作为实用指南。
核心结论
- 专家组确认临床前研究在围产期麻醉神经毒性领域的重要性,并欢迎新机制方法。
- 总结模型系统优缺点和提供报告指导有助于设计新实验和跨实验室结果解读。
研究设计与样本
- 2019年3月由SmartTots(FDA与IARS公私合作)主办会议,研究专家、麻醉期刊编辑和政府机构代表参加。
- 会议讨论围产期麻醉神经毒性临床前研究的严谨性和报告标准,形成专家意见报告。
主要发现
- 专家组确认临床前研究的重要性并欢迎新机制方法。
- 与会者认为总结特定模型系统优缺点和提供报告指导将有帮助。
- 报告包含对当前动物模型和报告标准的聚焦综述。
临床怎么用
- 作为设计和开展新临床前实验的实用指南和路线图。
- 帮助跨实验室解读围产期麻醉神经毒性临床前研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In March 2019, SmartTots, a public-private partnership between the US Food and Drug Administration and the International Anesthesia Research Society, hosted a meeting attended by research experts, anaesthesia journal editors, and government agency representatives to discuss the continued need for rigorous preclinical research and the importance of establishing reporting standards for the field of anaesthetic perinatal neurotoxicity. This group affirmed the importance of preclinical research in the field, and welcomed novel and mechanistic approaches to answer some of the field's largest questions. The attendees concluded that summarising the benefits and disadvantages of specific model systems, and providing guidance for reporting results, would be helpful for designing new experiments and interpreting results across laboratories. This expert opinion report is a summary of these discussions, and includes a focused review of current animal models and reporting standards for the field of perinatal anaesthetic neurotoxicity. This will serve as a practical guide and road map for novel and rigorous experimental work.
引用
- Chinn GA, Pearn ML, Vutskits L, et al. Standards for preclinical research and publications in developmental anaesthetic neurotoxicity: expert opinion statement from the SmartTots preclinical working group. Br J Anaesth. 2020. PMID: 32145876. doi:10.1016/j.bja.2020.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。